Kinnear Pharmaceuticals is a preclinical stage pharmaceutical company committed to the discovery, development and commercialization of naturally-inspired product candidates for diseases with large unmet clinical needs. Kinnear's initial focus is the development of ceragenin-based therapies. Ceragenins are synthetic non-peptide small molecule mimetics of endogenous host defense or antimicrobial peptides. Ceragenins exhibit similar multi-faceted activities to naturally-occurring antimicrobial peptides.